Single-Use Bioprocessing Connectors Market Report 2026

Single-Use Bioprocessing Connectors Market Overview

• Single-Use Bioprocessing Connectors market size has reached to $1.65 billion in 2025 • Expected to grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 18.9% • Growth Driver: Increasing Demand For Biosimilars Driving The Market Growth Due To Rising Biologic Drug Manufacturing Requirements • Market Trend: Innovative Disposable Connectors Driving Efficiency In Single-Use Bioprocessing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single-Use Bioprocessing Connectors Market?

Single-use bioprocessing connectors are disposable components designed to connect various parts of a bioprocessing system, such as tubing, bags, filters, and bioreactors, while ensuring sterile, leak-proof, and secure fluid transfer. These connectors support critical processes, including media preparation, fermentation, and purification, and eliminate the need for cleaning or sterilization between batches. The main products of single-use bioprocessing connectors are aseptic connectors and conventional connectors. Aseptic connectors are single-use devices designed to enable sterile fluid transfer in bioprocessing without the risk of contamination. They are used in various applications such as upstream bioprocessing, downstream bioprocessing, and fill-finish operations. These connectors are utilized by biopharmaceutical and pharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), and academic and research institutes.

What Is The Single-Use Bioprocessing Connectors Market Growth Forecast?

The single-use bioprocessing connectors market size is expected to see rapid growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 18.9%. The growth in the forecast period can be attributed to expansion of single-use technologies, integration of aseptic connectors in automated systems, increasing adoption in contract manufacturing, growth in biologics and cell therapy, focus on reducing cross-contamination risk. Major trends in the forecast period include adoption of disposable bioprocessing systems, focus on sterile and contamination-free fluid transfer, increasing upstream bioprocessing automation, shift toward single-use fill-finish operations, standardization of connector interfaces.

Global Single-Use Bioprocessing Connectors Market Segmentation

1) By Product: Aseptic Connectors, Conventional Connectors 2) By Application: Upstream Bioprocessing, Downstream Bioprocessing, Fill-Finish Operations 3) By End Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes Subsegments: 1) By Aseptic Connectors: Genderless Aseptic Connectors, Gendered Aseptic Connectors, Sterile Disconnectors 2) By Conventional Connectors: Luer Connectors, Tube-To-Tube Connectors, Fittings And Clamps

What Is The Driver Of The Single-Use Bioprocessing Connectors Market?

The increasing demand for biosimilars is expected to propel the growth of the single-use bioprocessing connectors market going forward. Biosimilars are biologic medical products that are highly similar to already approved biologic drugs, with no significant clinical differences in safety or effectiveness. The rising demand for biosimilars is primarily due to the rising prevalence of chronic diseases, as these conditions often require long-term biologic treatments, making cost-effective alternatives such as biosimilars a more accessible option for patients and healthcare systems. Single-use bioprocessing connectors support the manufacturing of biosimilars by enabling sterile, flexible, and contamination-free fluid transfer, which streamlines production processes, ensures product quality, reduces the risk of batch failures, and lowers overall operational costs, thereby accelerating time-to-market for biosimilar products. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, there were 33 biosimilar products approved by the FDA as of January 2022, with 21 available on the market. By 2023, the total number of FDA-approved biosimilars increased to 40, with 25 of them commercially available. Therefore, the increasing demand for biosimilars is driving the growth of the single-use bioprocessing connectors industry.

Key Players In The Global Single-Use Bioprocessing Connectors Market

Major companies operating in the single-use bioprocessing connectors market are Compagnie de Saint Gobain S A, Thermo Fisher Scientific Inc, Danaher Corporation, Merck KGaA, Sartorius AG, Repligen Corporation, Pall Corporation, Nordson Corporation, Watson Marlow Limited, Colder Products Company, Shanghai LePure Biotech Co Ltd, Qosina Corp, SaniSure GmbH, Ami Polymer Private Limited, Foxx Life Sciences LLC, Bio Link LLC, Liquidyne Process Technologies Inc, PharSol Technology Solutions Private Limited, BioPulse Solutions Inc, CPC Biopharma Connectors, AdvantaPure, Teknor Apex Healthcare

Global Single-Use Bioprocessing Connectors Market Trends and Insights

Major companies operating in the single-use bioprocessing connectors market are focusing on developing innovative products such as disposable bioprocess connectors to improve operational efficiency, reduce contamination risk, and streamline biomanufacturing processes. Disposable bioprocess connectors are single-use components designed to connect fluid transfer lines in biopharmaceutical manufacturing without the need for cleaning or sterilization. They help by reducing the risk of cross-contamination, minimizing cleaning validation requirements, and increasing process efficiency in sterile fluid handling. For instance, in April 2023, CPC Colder Products Company, a US-based plastics manufacturing company, launched the AseptiQuik W Series, the industry's largest genderless aseptic connectors with a 1-1/2-inch flow path, designed to enable high-volume sterile fluid transfer, significantly reducing fluid transfer times and enhancing efficiency in single-use bioprocessing applications by supporting the rapid transfer of hundreds of liters per minute, thereby improving operational throughput, minimizing contamination risks, and eliminating the need for cleaning and sterilization between batches.

What Are Latest Mergers And Acquisitions In The Single-Use Bioprocessing Connectors Market?

In October 2023, Getinge AB, a Sweden-based medical technology company, acquired High Purity New England Inc. for $120 million. With this acquisition, Getinge AB aims to strengthen its position in the fast-growing bioprocessing market by expanding its portfolio with High Purity New England Inc.’s custom single-use solutions that support the development and production of advanced therapies such as monoclonal antibodies, vaccines, and cell and gene therapies. High Purity New England Inc. is a US-based bioprocessing solutions company that specializes in designing, manufacturing, and distributing single-use technologies, including connectors, assemblies, pumps, and sensors used across drug development and manufacturing processes.

Regional Outlook

North America was the largest region in the single-use bioprocessing connectors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Single-Use Bioprocessing Connectors Market?

The single-use bioprocessing connectors market consists of sales of sterile quick connectors, push-to-connect fittings, quick connects or disconnects, tube welders and sealers, and sanitary clamps and fittings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.